---
title: "REGENXB priced $9.00 IPO of 10.0M shares plus 1.11M pre-funded warrants, raising ~$107.8M net"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293209009.md"
description: "REGENXB priced its public offering of 10,003,889 common shares at $9.00 and 1,111,111 pre-funded warrants at $8.9999. The underwriters exercised their full over-allotment option for an additional 1,667,250 shares. Net proceeds are expected to be approximately $107.8 million after deducting discounts and expenses. The offering is expected to close on July 20, 2026."
datetime: "2026-07-20T11:43:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293209009.md)
  - [en](https://longbridge.com/en/news/293209009.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293209009.md)
generator: "portal-rs"
---

# REGENXB priced $9.00 IPO of 10.0M shares plus 1.11M pre-funded warrants, raising ~$107.8M net

**REGENXB priced public offering of 10,003,889 common shares at $9.00 and 1,111,111 pre-funded warrants at $8.9999.**

**Key Highlights:**

-   Underwriting agreement sold 10,003,889 common shares at $9.00 and 1,111,111 pre-funded warrants at $8.9999.
-   Underwriters exercised full 30-day option for 1,667,250 additional shares; offering expected to close July 20, 2026.
-   Net proceeds expected to be approximately $107.8 million after underwriting discounts, commissions and expenses.
-   Pre-funded warrants exercisable at $0.0001 per share, exercisable any time and do not expire; holders have no stock rights until exercised.
-   Offering made under effective Form S-3 registration; underwriting agreement contains customary terms and indemnities.

Original SEC Filing: REGENXBIO Inc. \[ RGNX \] - 8-K - Jul. 20, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [RGNX.US](https://longbridge.com/en/quote/RGNX.US.md)

## Related News & Research

- [FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial](https://longbridge.com/en/news/298029915.md)
- [Precise Biometrics sets warrant exercise price at SEK 0.47 per share](https://longbridge.com/en/news/298683825.md)
- [Cabaletta Bio raises $128.2 million from common stock warrant exercises](https://longbridge.com/en/news/298915127.md)
- [Laser Photonics issues warrants in $7.9 million public offering at $0.75 per share](https://longbridge.com/en/news/298656695.md)
- [Sunshine Biopharma cuts warrant exercise price to 1.2](https://longbridge.com/en/news/298769650.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**